- Home
- ABVX vs GAMB Comparison
ABVX vs GAMB Comparison
Compare ABVX & GAMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABVX
- GAMB
- Stock Information
- Founded
- ABVX 2013
- GAMB 2006
- Country
- ABVX France
- GAMB Jersey
- Employees
- ABVX N/A
- GAMB N/A
- Industry
- ABVX
- GAMB Services-Misc. Amusement & Recreation
- Sector
- ABVX
- GAMB Consumer Discretionary
- Exchange
- ABVX Nasdaq
- GAMB Nasdaq
- Market Cap
- ABVX 407.6M
- GAMB N/A
- IPO Year
- ABVX N/A
- GAMB 2021
- Fundamental
- Price
- ABVX $6.25
- GAMB $12.59
- Analyst Decision
- ABVX Buy
- GAMB Strong Buy
- Analyst Count
- ABVX 8
- GAMB 7
- Target Price
- ABVX $34.63
- GAMB $16.71
- AVG Volume (30 Days)
- ABVX 317.1K
- GAMB 448.5K
- Earning Date
- ABVX 03-24-2025
- GAMB 03-20-2025
- Dividend Yield
- ABVX N/A
- GAMB N/A
- EPS Growth
- ABVX N/A
- GAMB 78.72
- EPS
- ABVX N/A
- GAMB 0.84
- Revenue
- ABVX $11,172,999.00
- GAMB $127,182,000.00
- Revenue This Year
- ABVX $306.91
- GAMB $34.55
- Revenue Next Year
- ABVX N/A
- GAMB $14.33
- P/E Ratio
- ABVX N/A
- GAMB $15.02
- Revenue Growth
- ABVX 135.94
- GAMB 17.05
- 52 Week Low
- ABVX $5.50
- GAMB $7.52
- 52 Week High
- ABVX $16.63
- GAMB $17.14
- Technical
- Relative Strength Index (RSI)
- ABVX 40.22
- GAMB 43.14
- Support Level
- ABVX $5.60
- GAMB $12.00
- Resistance Level
- ABVX $7.85
- GAMB $14.02
- Average True Range (ATR)
- ABVX 0.60
- GAMB 0.59
- MACD
- ABVX -0.05
- GAMB 0.10
- Stochastic Oscillator
- ABVX 28.89
- GAMB 44.30
About ABVX Abivax SA American
Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD.